Safe Access: Trial With RemovAid Device

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

November 9, 2020

Study Completion Date

April 1, 2021

Conditions
Removal of a Contraceptive Subdermal Implant
Interventions
DEVICE

RemovAid device + lidocaine patch

The RemovAid device incises the skin and grasps the implant for removal. A lidocaine patch will be used prior to incision.

PROCEDURE

Standard technique + lidocaine injection

Using scalpel, tweezers, and forceps to remove a subdermal implant. A lidocaine injection will be used prior to incision.

DEVICE

RemovAid device + lidocaine injection

The RemovAid device incises the skin and grasps the implant for removal. A lidocaine injection will be used prior to incision.

Trial Locations (1)

Unknown

Kawempe Referral Hospital, Kampala

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Mulago Hospital, Uganda

OTHER

collaborator

FHI 360

OTHER

lead

RemovAid AS

INDUSTRY

NCT04120337 - Safe Access: Trial With RemovAid Device | Biotech Hunter | Biotech Hunter